Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center
Identifieur interne : 00A700 ( Main/Exploration ); précédent : 00A699; suivant : 00A701Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center
Auteurs : Michael S. Sabel [États-Unis] ; John F. Gibbs [États-Unis] ; Richard Cheney [États-Unis] ; Brian P. Mckinley [États-Unis] ; James S. Lee [États-Unis] ; William G. Kraybill [États-Unis]Source :
- Surgery [ 0039-6060 ] ; 2000.
Abstract
Background. Sentinel lymph node biopsy (SLNB) has rapidly evolved into the standard of care for clinically node-negative melanoma. Since adopting sentinel lymph node (SLN) technology in 1993, we have periodically reviewed our institution's results and made several modifications. Methods. From January 1993 to December 1998, 182 patients with clinically node-negative primary cutaneous melanoma underwent SLNB. Charts were retrospectively reviewed and assessed for the technique for the identification of the SLN, the pathologic analysis, and the use of intraoperative frozen section. Results. The accuracy of SLN identification improved from 91% to 100% with the combination of isosulfan blue dye and radiolabeled colloid over isosulfan blue dye alone. Routine versus selective lymphoscintigraphy identified 7 in-transit SLNs and increased detection of dual nodal basin drainage (15%-27%). Identification of micrometastases in the SLN increased from 14% to 24% after a modification of pathologic evaluation. The positive SLN was the only involved node in most patients (80%). Intraoperative frozen section had a sensitivity of 58% and was of benefit in only 13 of 124 patients (10%). Conclusions. Several modifications to the identification of the SLNs and the detection of metastatic melanoma have improved our outcome with SLNB. A careful, periodic review of results to identify areas for improvement at each institution is crucial to the success of SLNB for melanoma. (Surgery 2000;128:556-63.)
Url:
DOI: 10.1067/msy.2000.108053
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 007358
- to stream Istex, to step Curation: 007358
- to stream Istex, to step Checkpoint: 003221
- to stream Main, to step Merge: 00AC38
- to stream Main, to step Curation: 00A700
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center</title><author><name sortKey="Sabel, Michael S" sort="Sabel, Michael S" uniqKey="Sabel M" first="Michael S." last="Sabel">Michael S. Sabel</name></author><author><name sortKey="Gibbs, John F" sort="Gibbs, John F" uniqKey="Gibbs J" first="John F." last="Gibbs">John F. Gibbs</name></author><author><name sortKey="Cheney, Richard" sort="Cheney, Richard" uniqKey="Cheney R" first="Richard" last="Cheney">Richard Cheney</name></author><author><name sortKey="Mckinley, Brian P" sort="Mckinley, Brian P" uniqKey="Mckinley B" first="Brian P." last="Mckinley">Brian P. Mckinley</name></author><author><name sortKey="Lee, James S" sort="Lee, James S" uniqKey="Lee J" first="James S." last="Lee">James S. Lee</name></author><author><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G." last="Kraybill">William G. Kraybill</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F68800D8A99F10A5BA21CDC902A08268973F78F4</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1067/msy.2000.108053</idno><idno type="url">https://api.istex.fr/document/F68800D8A99F10A5BA21CDC902A08268973F78F4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007358</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007358</idno><idno type="wicri:Area/Istex/Curation">007358</idno><idno type="wicri:Area/Istex/Checkpoint">003221</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003221</idno><idno type="wicri:doubleKey">0039-6060:2000:Sabel M:evolution:of:sentinel</idno><idno type="wicri:Area/Main/Merge">00AC38</idno><idno type="wicri:Area/Main/Curation">00A700</idno><idno type="wicri:Area/Main/Exploration">00A700</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center</title><author><name sortKey="Sabel, Michael S" sort="Sabel, Michael S" uniqKey="Sabel M" first="Michael S." last="Sabel">Michael S. Sabel</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author><author><name sortKey="Gibbs, John F" sort="Gibbs, John F" uniqKey="Gibbs J" first="John F." last="Gibbs">John F. Gibbs</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author><author><name sortKey="Cheney, Richard" sort="Cheney, Richard" uniqKey="Cheney R" first="Richard" last="Cheney">Richard Cheney</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author><author><name sortKey="Mckinley, Brian P" sort="Mckinley, Brian P" uniqKey="Mckinley B" first="Brian P." last="Mckinley">Brian P. Mckinley</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author><author><name sortKey="Lee, James S" sort="Lee, James S" uniqKey="Lee J" first="James S." last="Lee">James S. Lee</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author><author><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G." last="Kraybill">William G. Kraybill</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Division of Surgery and Department of Pathology, Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Surgery</title><title level="j" type="abbrev">YMSY</title><idno type="ISSN">0039-6060</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">128</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="556">556</biblScope><biblScope unit="page" to="563">563</biblScope></imprint><idno type="ISSN">0039-6060</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0039-6060</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background. Sentinel lymph node biopsy (SLNB) has rapidly evolved into the standard of care for clinically node-negative melanoma. Since adopting sentinel lymph node (SLN) technology in 1993, we have periodically reviewed our institution's results and made several modifications. Methods. From January 1993 to December 1998, 182 patients with clinically node-negative primary cutaneous melanoma underwent SLNB. Charts were retrospectively reviewed and assessed for the technique for the identification of the SLN, the pathologic analysis, and the use of intraoperative frozen section. Results. The accuracy of SLN identification improved from 91% to 100% with the combination of isosulfan blue dye and radiolabeled colloid over isosulfan blue dye alone. Routine versus selective lymphoscintigraphy identified 7 in-transit SLNs and increased detection of dual nodal basin drainage (15%-27%). Identification of micrometastases in the SLN increased from 14% to 24% after a modification of pathologic evaluation. The positive SLN was the only involved node in most patients (80%). Intraoperative frozen section had a sensitivity of 58% and was of benefit in only 13 of 124 patients (10%). Conclusions. Several modifications to the identification of the SLNs and the detection of metastatic melanoma have improved our outcome with SLNB. A careful, periodic review of results to identify areas for improvement at each institution is crucial to the success of SLNB for melanoma. (Surgery 2000;128:556-63.)</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Sabel, Michael S" sort="Sabel, Michael S" uniqKey="Sabel M" first="Michael S." last="Sabel">Michael S. Sabel</name></region><name sortKey="Cheney, Richard" sort="Cheney, Richard" uniqKey="Cheney R" first="Richard" last="Cheney">Richard Cheney</name><name sortKey="Gibbs, John F" sort="Gibbs, John F" uniqKey="Gibbs J" first="John F." last="Gibbs">John F. Gibbs</name><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G." last="Kraybill">William G. Kraybill</name><name sortKey="Lee, James S" sort="Lee, James S" uniqKey="Lee J" first="James S." last="Lee">James S. Lee</name><name sortKey="Mckinley, Brian P" sort="Mckinley, Brian P" uniqKey="Mckinley B" first="Brian P." last="Mckinley">Brian P. Mckinley</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A700 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A700 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F68800D8A99F10A5BA21CDC902A08268973F78F4
|texte= Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center
}}
| This area was generated with Dilib version V0.6.31. |  |